The present technology relates generally to devices and methods for removing obstructions from body lumens. Some embodiments of the present technology relate to removing clot material from blood vessels.
Many medical procedures use medical device(s) to remove an obstruction (such as clot material) from a body lumen, vessel, or other organ. An inherent risk in such procedures is that mobilizing or otherwise disturbing the obstruction can potentially create further harm if the obstruction or a fragment thereof dislodges from the retrieval device. If all or a portion of the obstruction breaks free from the device and flows downstream, it is highly likely that the free material will become trapped in smaller and more tortuous anatomy. In many cases, the physician will no longer be able to use the same retrieval device to again remove the obstruction because the device may be too large and/or immobile to move the device to the site of the new obstruction.
Even in successful procedures, a physician must be cautious to prevent the walls of the vessel or body lumen from imparting undesired forces to shear or dislodge the obstruction as it passes through the vasculature during removal. These forces have the potential of fragmenting the obstruction. In some cases, the obstruction can simply break free from the retrieval device and can lodge in a new area causing more concern than the original blockage.
Procedures for treating ischemic stroke by restoring flow within the cerebral vasculature are subject to the above concerns. The brain relies on its arteries and veins to supply oxygenated blood from the heart and lungs and to remove carbon dioxide and cellular waste from brain tissue. Blockages that interfere with this blood supply eventually cause the brain tissue to stop functioning. If the disruption in blood occurs for a sufficient amount of time, the continued lack of nutrients and oxygen causes irreversible cell death (infarction). Accordingly, it is desirable to provide immediate medical treatment of an ischemic stroke. To access the cerebral vasculature, a physician typically advances a catheter from a remote part of the body (typically a leg) through the abdominal vasculature and into the cerebral region of the vasculature. Once within the cerebral vasculature, the physician deploys a device for retrieval of the obstruction causing the blockage. Concerns about dislodged obstructions or the migration of dislodged fragments increases the duration of the procedure at time when restoration of blood flow is paramount. Furthermore, a physician might be unaware of one or more fragments that dislodge from the initial obstruction and cause blockage of smaller more distal vessels.
Many physicians currently perform thrombectomies (i.e. clot removal) with stents to resolve ischemic stroke. Typically, the physician deploys a stent into the clot in an attempt to push the clot to the side of the vessel and re-establish blood flow. Tissue plasminogen activator (“tPA”) is often injected into the bloodstream through an intravenous line to break down a clot. However, it takes time for the tPA to reach the clot because the tPA must travel through the vasculature and only begins to break up the clot once it reaches the clot material. tPA is also often administered to supplement the effectiveness of the stent. Yet, if attempts at clot dissolution are ineffective or incomplete, the physician can attempt to remove the stent while it is expanded against or enmeshed within the clot. In doing so, the physician must effectively drag the clot through the vasculature, in a proximal direction, into a guide catheter located within vessels in the patient's neck (typically the carotid artery). While this procedure has been shown to be effective in the clinic and is easy for the physician to perform, there remain some distinct disadvantages to using this approach.
For example, one disadvantage is that the stent may not sufficiently retain the clot as it pulls the clot to the catheter. In such a case, some or all of the clot might remain within the vasculature. Another risk is that as the stent mobilizes the clot from the original blockage site, the clot might not adhere to the stent as the stent is withdrawn toward the catheter. This is a particular risk when passing through bifurcations and tortuous anatomy. Furthermore, blood flow can carry the clot (or fragments of the clot) into a branching vessel at a bifurcation. If the clot is successfully brought to the end of the guide catheter in the carotid artery, yet another risk is that the clot may be “stripped” or “sheared” from the stent as the stent enters the guide catheter. Regardless, simply dragging an expanded stent (either fully or partially expanded) can result in undesired trauma to the vessel. In most cases, since the stent is oversized compared to the vessel, dragging a fixed metallic (or other) structure can pull the arteries and/or strip the cellular lining from the vessel, causing further trauma such as a hemorrhagic stroke (leakage of blood from a cerebral vessel). Also, the stent can become lodged on plaque on the vessel walls resulting in further vascular damage.
In view of the above, there remains a need for improved devices and methods that can remove occlusions from body lumens and/or vessels.
At least some of the embodiments disclosed herein involves devices, systems, and methods for retrieving clot material from a blood vessel lumen. For example, some embodiments are directed to a retrieval device (such as a clot retrieval device) that includes an elongated shaft configured to be intravascularly positioned at or adjacent clot material within a blood vessel lumen, and a retrieval assembly coupled to a distal region of the elongated shaft. The retrieval assembly may include a flexible cover and a capture structure. The retrieval assembly may be deployed within the blood vessel lumen at or near the clot material such that the capture structure engages or otherwise becomes enmeshed with at least a portion of the clot material, and at least a portion of the cover presses outward against the blood vessel wall proximal of the capture structure. Pulling the elongated shaft proximally everts the cover over the capture structure such that the cover at least partially ensheathes the capture structure and associated clot material. The retrieval assembly can then be withdrawn to remove the retrieval device and associated clot material from the patient.
In at least some embodiments of the present technology, a retractor device can be used to transform the retrieval device from a deployed position to a delivery position for re-use. In the deployed position, the cover at least partially ensheathes the capture structure. In the delivery position, the cover ensheathes less of the capture than in the deployed position (e.g., ensheathes no portion of the capture structure). In some embodiments, the retractor can have a tubular structure configured to slidably receive the retrieval device. The tubular structure can have a length no greater than twice the length of the capture structure.
The subject technology is illustrated, for example, according to various aspects described below. Various examples of aspects of the subject technology are described as numbered clauses (1, 2, 3, etc.) for convenience. These are provided as examples and do not limit the subject technology. It is noted that any of the dependent clauses may be combined in any combination, and placed into a respective independent clause, e.g., clause 1, clause 11, or clause 20. The other clauses can be presented in a similar manner.
Additional features and advantages of the subject technology will be set forth in the description below, and in part will be apparent from the description, or may be learned by practice of the subject technology. The advantages of the subject technology will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.
It is to be understood that both the foregoing general description and the following detailed description are explanatory and are intended to provide examples and further explanation of the subject technology as claimed.
Many aspects of the present technology can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale. Instead, emphasis is placed on illustrating clearly the principles of the present disclosure.
The present technology provides devices, systems, and methods for removing clot material from a blood vessel lumen. Although many of the embodiments are described below with respect to devices, systems, and methods for treating an ischemic stroke or cerebral embolism, other applications and other embodiments in addition to those described herein are within the scope of the technology. For example, the retrieval devices of the present technology may be used to remove emboli or other material from body lumens other than blood vessels (e.g., the digestive tract, etc.) and/or may be used to remove emboli from blood vessels outside of the brain (e.g., pulmonary blood vessels, blood vessels within the legs, etc.). In addition, the retrieval devices of the present technology may be used to remove luminal obstructions other than clot material (e.g., plaque, foreign bodies, resected tissue, etc.).
An overview of the retrieval devices of the present technology and associated methods of use is described below with reference to
The capture structure 100 has a low-profile configuration (not shown) when constrained within a delivery catheter (e.g., a microcatheter) and an expanded configuration for securing and/or engaging clot material or other obstructions within a blood vessel lumen (e.g., a cerebral blood vessel lumen) and/or for restoring blood flow within the blood vessel. The capture structure 100 has a proximal portion 100a coupled to the shaft 12 and a distal portion 100b. The capture structure 100 further includes an open cell framework or body 108 (
Referring again to
The cover 200 includes a first end portion 200a coupled to the shaft 12 via the connection assembly 120, a free second end portion 200b, and a cover wall 200c extending between the first end portion 200a and the second end portion 200b. As used herein to describe the second end portion 200b of the cover 200, the term “free” refers to a portion of the cover 200 that is not fixed to the elongated shaft 12 and may move radially and/or longitudinally with respect to the shaft 12. The cover 200 is flexible such that it is movable between a first position (
The cover 200 can comprise a mesh and/or braid of a plurality of wires (e.g., filaments, threads, sutures, fibers or the like) that have been interwoven to form a structure having openings (e.g., a porous fabric). The mesh and/or braid can be composed of metals, polymers, composites, and/or biologic materials. Polymer materials can include Dacron, polyester, polypropylene, nylon, Teflon, polytetrafluoroethylene (PTFE), tetrafluoroethylene, polyethylene terephthalate, polyactic acid (PLA) silicone, polyurethane, polyethylene, polycarbonate, styrene, polyimide, PEBAX, Hytrel, polyvinyl chloride, high-density polyethylene, low-density polyethylene, polyether ether ketone (PEEK), rubber, latex, and/or other suitable polymers known in the art. Other materials known in the art of elastic implants can also be used. Metal materials can include, but are not limited to, nickel-titanium alloys (e.g. Nitinol), platinum, cobalt-chromium alloys, stainless steel, tungsten or titanium. In some embodiments, metal filaments may be highly polished and/or surface treated to further improve their hemocompatibility. The cover 200 can be constructed solely from metallic materials without the inclusion of any polymer materials, solely from polymer materials without the inclusion of any metallic materials, or a combination of polymer and metallic materials.
In some embodiments, some or all of the wires of the cover 200 are drawn-filled tube (“DFT”) wires having a radiopaque core (e.g., platinum, tantalum, gold, tungsten, etc.) surrounded by a superelastic material (e.g., Nitinol, a cobalt-chromium alloy, etc.). The radiopaque core may comprise about 5% to about 50% (e.g., 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%) of the total-cross-sectional area of the individual wires. In some embodiments, the cover 200 may have 72-144 total wires (e.g., 72, 96 128, 144, etc.) Moreover, some or all of the wires may have a wire diameter of about 0.005 inches to about 0.015 inches (e.g., 0.008 inches, 0.01 inches, etc.). In some embodiments, all of the wires have the same diameter, and in other embodiments some of the wires have different diameters.
As shown in
As shown in
In some instances, the physician (i.e., a “user”) using the retrieval device 10 may wish to re-use the retrieval device 10 after it has been delivered within a vessel. For example, the user may wish to re-use the retrieval device 10 in a second attempt to remove clot material CM from a vessel. However, once the clot retrieval assembly 14 is retracted proximally within the delivery catheter 2 (e.g., to remove the clot material CM), the cover 200 is in the second position (
As shown in
In the embodiment illustrated in
The retractor 300 can further comprise a handle 306 extending from the tubular structure 302 and configured to be gripped by a user when the retractor 300 is used to move the cover 200 from the second position to the first position. The handle 306 can be coupled to the tubular structure 302 nearer to the proximal portion 314 of the tubular structure 302 than the distal portion 312. In some embodiments, the handle 306 has at least a generally planar shape and is coupled to the tubular structure 302 such that the handle 306 is perpendicular to a plane extending through the slot 308. In some embodiments, the handle 306 is attached at a different portion of the tubular structure 302 and can have a different shape or relative size. For example, the handle 306 can be a ring or other open shape that a user can grip.
The retractor 300 can be made out of a plastic or other materials. For example, in some embodiments, the retractor 300 is formed from high-density polyethylene (“HDPE”). Suitable materials can be injection molded, compression molded, or three-dimensionally printed into shape. Other well-known methods of manufacture can be used to form the retractor 300.
To move the cover 200 from the second position to the first position, the retrieval device 10 can be slidably disposed within the channel 304 such that the distal terminus 101 of the capture structure 100 is within channel 304. The cover 200 can then be secured against the outside surface 316 while the capture structure 100 is advanced distally through channel 304 to expose the capture structure 100. One advantage of using the retractor 300 is that the rigid external structure of the tubular structure 302 inhibits the cover 200 of the retrieval device from snagging on the capture structure 100 as the cover 200 moves from the second position to the first position. For example, without using the retractor 300, a user would need to grip either or both of the elongated shaft 12 and retrieval assembly 14 while attempting to manipulate the cover 200 from the second position to the first position. In doing so, without using the retractor 300, the distal terminus 101 of the capture structure 100 will frequently snag on the cover 200 when the cover 200 is moved proximally. This can increase the time required to prepare the retrieval device 10 for redeployment, and potentially damage the cover 200.
In the embodiment shown in
The stop 422 defines a specific location within the retractor 400 for positioning the retrieval device 10. For example, the stop 422 can be located within the channel 404 such that when the retrieval assembly 14 engages the stop 422, the distal terminus 101 of the capture structure 100 is within the channel 404. The location of the stop 422 can also prevent the retrieval assembly 14 from being placed needlessly deep into the channel 404 and/or from sliding in the proximal direction out of the channel 404 during retraction of the cover 200. If placed too deep, more time and motion are required for manipulating the cover 200 onto the tubular structure 402. As illustrated in
Several aspects of methods for using the retractor 300 shown in
As illustrated in
Still referring to
As shown in
Next, the cover 200 is secured against the outside surface 316 of the tubular structure 302. For example, the user can squeeze the portion of the cover 200 that is over the tubular structure 302 to clamp the cover 200 against the outside surface 316 of the tubular structure 302. In some embodiments, the cover 200 can be secured against the outside surface 316 of the tubular structure 302 by other mechanisms, such as a clamp or tie fastened around the portion of the cover on the outside surface 316.
In a next step illustrated in
As shown in
As illustrated in
This disclosure is not intended to be exhaustive or to limit the present technology to the precise forms disclosed herein. Although specific embodiments are disclosed herein for illustrative purposes, various equivalent modifications are possible without deviating from the present technology, as those of ordinary skill in the relevant art will recognize. In some cases, well-known structures and functions have not been shown and/or described in detail to avoid unnecessarily obscuring the description of the embodiments of the present technology. Although steps of methods may be presented herein in a particular order, in alternative embodiments the steps may have another suitable order. Similarly, certain aspects of the present technology disclosed in the context of particular embodiments can be combined or eliminated in other embodiments. Furthermore, while advantages associated with some embodiments may have been disclosed in the context of those embodiments, other embodiments can also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages or other advantages disclosed herein to fall within the scope of the present technology. Accordingly, this disclosure and associated technology can encompass other embodiments not expressly shown and/or described herein.
Throughout this disclosure, the singular terms “a,” “an,” and “the” include plural referents unless the context clearly indicates otherwise. Similarly, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the terms “comprising” and the like are used throughout this disclosure to mean including at least the recited feature(s) such that any greater number of the same feature(s) and/or one or more additional types of features are not precluded. Reference herein to “one embodiment,” “an embodiment,” or similar formulations means that a particular feature, structure, operation, or characteristic described in connection with the embodiment can be included in at least one embodiment of the present technology. Thus, the appearances of such phrases or formulations herein are not necessarily all referring to the same embodiment. Furthermore, various particular features, structures, operations, or characteristics may be combined in any suitable manner in one or more embodiments.
The present application is a divisional of U.S. patent application Ser. No. 15/626,265, filed Jun. 19, 2017, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2918919 | Wallace | Dec 1959 | A |
2943626 | Enrico | Jul 1960 | A |
3996938 | Clark, III | Dec 1976 | A |
4347846 | Dormia | Sep 1982 | A |
4611594 | Grayhack et al. | Sep 1986 | A |
4650466 | Luther | Mar 1987 | A |
4657020 | Lifton | Apr 1987 | A |
4699147 | Chilson et al. | Oct 1987 | A |
4790812 | Hawkins, Jr. et al. | Dec 1988 | A |
4807626 | Mcgirr | Feb 1989 | A |
4832055 | Palestrant | May 1989 | A |
4873978 | Ginsburg | Oct 1989 | A |
4969891 | Gewertz | Nov 1990 | A |
4998539 | Delsanti | Mar 1991 | A |
5034001 | Garrison et al. | Jul 1991 | A |
5057114 | Wittich et al. | Oct 1991 | A |
5059178 | Ya | Oct 1991 | A |
5102415 | Guenther et al. | Apr 1992 | A |
5147400 | Kaplan et al. | Sep 1992 | A |
5152777 | Goldberg et al. | Oct 1992 | A |
5192286 | Phan et al. | Mar 1993 | A |
5300086 | Gory et al. | Apr 1994 | A |
5329942 | Gunther et al. | Jul 1994 | A |
5443478 | Purdy | Aug 1995 | A |
5449372 | Schmaltz et al. | Sep 1995 | A |
5458375 | Anspach, Jr. et al. | Oct 1995 | A |
5490859 | Mische et al. | Feb 1996 | A |
5496330 | Bates et al. | Mar 1996 | A |
5509900 | Kirkman | Apr 1996 | A |
5653684 | Laptewicz et al. | Aug 1997 | A |
5658296 | Bates et al. | Aug 1997 | A |
5709704 | Nott et al. | Jan 1998 | A |
5733302 | Myler et al. | Mar 1998 | A |
5741325 | Chaikof et al. | Apr 1998 | A |
5792156 | Perouse | Aug 1998 | A |
5827324 | Cassell et al. | Oct 1998 | A |
5846251 | Hart | Dec 1998 | A |
5895398 | Wensel et al. | Apr 1999 | A |
5911710 | Barry et al. | Jun 1999 | A |
5941869 | Patterson et al. | Aug 1999 | A |
5947995 | Samuels | Sep 1999 | A |
5968090 | Ratcliff et al. | Oct 1999 | A |
5971938 | Hart et al. | Oct 1999 | A |
5972019 | Engelson et al. | Oct 1999 | A |
5984957 | Laptewicz, Jr. et al. | Nov 1999 | A |
6001118 | Daniel et al. | Dec 1999 | A |
6033394 | Vidlund et al. | Mar 2000 | A |
6042598 | Tsugita et al. | Mar 2000 | A |
6053932 | Daniel et al. | Apr 2000 | A |
6066149 | Samson et al. | May 2000 | A |
6066158 | Engelson et al. | May 2000 | A |
6096053 | Bates | Aug 2000 | A |
6099534 | Bates et al. | Aug 2000 | A |
6146403 | St. Germain | Nov 2000 | A |
6159220 | Gobron et al. | Dec 2000 | A |
6165200 | Tsugita et al. | Dec 2000 | A |
6168603 | Leslie et al. | Jan 2001 | B1 |
6174318 | Bates et al. | Jan 2001 | B1 |
6176873 | Ouchi | Jan 2001 | B1 |
6190394 | Lind et al. | Feb 2001 | B1 |
6217609 | Haverkost | Apr 2001 | B1 |
6221006 | Dubrul et al. | Apr 2001 | B1 |
6238412 | Dubrul | May 2001 | B1 |
6245088 | Lowery | Jun 2001 | B1 |
6245089 | Daniel et al. | Jun 2001 | B1 |
6248113 | Fina | Jun 2001 | B1 |
6264664 | Avellanet | Jul 2001 | B1 |
6302895 | Gobron et al. | Oct 2001 | B1 |
6309399 | Barbut et al. | Oct 2001 | B1 |
6348056 | Bates et al. | Feb 2002 | B1 |
6350266 | White et al. | Feb 2002 | B1 |
6364895 | Greenhalgh | Apr 2002 | B1 |
6371971 | Tsugita et al. | Apr 2002 | B1 |
6383195 | Richard | May 2002 | B1 |
6383196 | Leslie et al. | May 2002 | B1 |
6391044 | Yadav et al. | May 2002 | B1 |
6402771 | Palmer et al. | Jun 2002 | B1 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6416505 | Fleischman et al. | Jul 2002 | B1 |
6425909 | Dieck et al. | Jul 2002 | B1 |
6436112 | Wensel et al. | Aug 2002 | B2 |
6443972 | Bosma et al. | Sep 2002 | B1 |
6458139 | Palmer et al. | Oct 2002 | B1 |
6485497 | Wensel et al. | Nov 2002 | B2 |
6494884 | Gifford, III et al. | Dec 2002 | B2 |
6506204 | Mazzocchi | Jan 2003 | B2 |
6514273 | Voss et al. | Feb 2003 | B1 |
6530935 | Wensel et al. | Mar 2003 | B2 |
6540657 | Cross, III et al. | Apr 2003 | B2 |
6540768 | Diaz et al. | Apr 2003 | B1 |
6551342 | Shen et al. | Apr 2003 | B1 |
6575997 | Palmer et al. | Jun 2003 | B1 |
6585753 | Eder et al. | Jul 2003 | B2 |
6592605 | Lenker et al. | Jul 2003 | B2 |
6592607 | Palmer et al. | Jul 2003 | B1 |
6602271 | Adams et al. | Aug 2003 | B2 |
6605102 | Mazzocchi et al. | Aug 2003 | B1 |
6610077 | Hancock et al. | Aug 2003 | B1 |
6616679 | Khosravi et al. | Sep 2003 | B1 |
6620148 | Tsugita | Sep 2003 | B1 |
6635068 | Dubrul et al. | Oct 2003 | B1 |
6636758 | Sanchez et al. | Oct 2003 | B2 |
6638245 | Miller et al. | Oct 2003 | B2 |
6638293 | Makower et al. | Oct 2003 | B1 |
6641590 | Palmer et al. | Nov 2003 | B1 |
6645199 | Jenkins et al. | Nov 2003 | B1 |
6652505 | Tsugita | Nov 2003 | B1 |
6652548 | Evans et al. | Nov 2003 | B2 |
6660021 | Palmer et al. | Dec 2003 | B1 |
6663650 | Sepetka et al. | Dec 2003 | B2 |
6673042 | Samson et al. | Jan 2004 | B1 |
6679893 | Tran | Jan 2004 | B1 |
6685738 | Chouinard et al. | Feb 2004 | B2 |
6692508 | Wensel et al. | Feb 2004 | B2 |
6692509 | Wensel et al. | Feb 2004 | B2 |
6695858 | Dubrul et al. | Feb 2004 | B1 |
6702782 | Miller et al. | Mar 2004 | B2 |
6730104 | Sepetka et al. | May 2004 | B1 |
6745080 | Koblish | Jun 2004 | B2 |
6746468 | Sepetka et al. | Jun 2004 | B1 |
6749619 | Ouriel et al. | Jun 2004 | B2 |
6755813 | Ouriel et al. | Jun 2004 | B2 |
6800080 | Bates | Oct 2004 | B1 |
6824545 | Sepetka et al. | Nov 2004 | B2 |
6855155 | Denardo et al. | Feb 2005 | B2 |
6872211 | White et al. | Mar 2005 | B2 |
6872216 | Daniel et al. | Mar 2005 | B2 |
6890341 | Dieck et al. | May 2005 | B2 |
6893431 | Naimark et al. | May 2005 | B2 |
6905503 | Gifford, III et al. | Jun 2005 | B2 |
6913612 | Palmer et al. | Jul 2005 | B2 |
6936059 | Belef | Aug 2005 | B2 |
6939362 | Boyle et al. | Sep 2005 | B2 |
6945977 | Demarais et al. | Sep 2005 | B2 |
6953465 | Dieck et al. | Oct 2005 | B2 |
6964672 | Brady et al. | Nov 2005 | B2 |
7004955 | Shen et al. | Feb 2006 | B2 |
7004956 | Palmer et al. | Feb 2006 | B2 |
7037320 | Brady et al. | May 2006 | B2 |
7041126 | Shin et al. | May 2006 | B2 |
7048014 | Hyodoh et al. | May 2006 | B2 |
7058456 | Pierce | Jun 2006 | B2 |
7097653 | Freudenthal et al. | Aug 2006 | B2 |
7101380 | Khachin et al. | Sep 2006 | B2 |
7169165 | Belef et al. | Jan 2007 | B2 |
7179273 | Palmer et al. | Feb 2007 | B1 |
7182771 | Houser et al. | Feb 2007 | B1 |
7235061 | Tsugita | Jun 2007 | B2 |
7240516 | Pryor | Jul 2007 | B2 |
7399308 | Borillo et al. | Jul 2008 | B2 |
7534252 | Sepetka et al. | May 2009 | B2 |
7578830 | Kusleika et al. | Aug 2009 | B2 |
7621870 | Berrada et al. | Nov 2009 | B2 |
7837702 | Bates | Nov 2010 | B2 |
8070791 | Ferrera et al. | Dec 2011 | B2 |
8088140 | Ferrera et al. | Jan 2012 | B2 |
8105333 | Sepetka et al. | Jan 2012 | B2 |
8197493 | Ferrera et al. | Jun 2012 | B2 |
8603014 | Alleman et al. | Dec 2013 | B2 |
8795305 | Martin | Aug 2014 | B2 |
8837800 | Bammer et al. | Sep 2014 | B1 |
9119656 | Bose et al. | Sep 2015 | B2 |
9126018 | Garrison | Sep 2015 | B1 |
9211132 | Bowman | Dec 2015 | B2 |
9241699 | Kume et al. | Jan 2016 | B1 |
9254371 | Martin | Feb 2016 | B2 |
9265512 | Garrison et al. | Feb 2016 | B2 |
9308007 | Cully et al. | Apr 2016 | B2 |
9399118 | Kume et al. | Jul 2016 | B2 |
9427244 | Lund-Clausen | Aug 2016 | B2 |
9445828 | Turjman et al. | Sep 2016 | B2 |
9445829 | Brady et al. | Sep 2016 | B2 |
9463036 | Brady | Oct 2016 | B2 |
9492637 | Garrison et al. | Nov 2016 | B2 |
9539022 | Bowman | Jan 2017 | B2 |
9561345 | Garrison et al. | Feb 2017 | B2 |
9579119 | Cully et al. | Feb 2017 | B2 |
9585741 | Ma | Mar 2017 | B2 |
9642635 | Vale et al. | May 2017 | B2 |
9655633 | Leynov et al. | May 2017 | B2 |
9717519 | Rosenbluth | Aug 2017 | B2 |
9737318 | Monstadt et al. | Aug 2017 | B2 |
9770251 | Bowman et al. | Sep 2017 | B2 |
9801643 | Hansen et al. | Oct 2017 | B2 |
9861783 | Garrison et al. | Jan 2018 | B2 |
9962178 | Greenhalgh | May 2018 | B2 |
9993257 | Losordo et al. | Jun 2018 | B2 |
10028782 | Orion | Jul 2018 | B2 |
10029008 | Creighton | Jul 2018 | B2 |
10039906 | Kume et al. | Aug 2018 | B2 |
10327883 | Yachia | Jun 2019 | B2 |
20010041909 | Tsugita et al. | Nov 2001 | A1 |
20010044632 | Daniel et al. | Nov 2001 | A1 |
20010044634 | Don et al. | Nov 2001 | A1 |
20010051810 | Dubrul et al. | Dec 2001 | A1 |
20020002396 | Fulkerson | Jan 2002 | A1 |
20020004667 | Adams et al. | Jan 2002 | A1 |
20020026211 | Khosravi et al. | Feb 2002 | A1 |
20020058904 | Boock et al. | May 2002 | A1 |
20020062135 | Mazzocchi et al. | May 2002 | A1 |
20020072764 | Sepetka et al. | Jun 2002 | A1 |
20020072765 | Mazzocchi | Jun 2002 | A1 |
20020082558 | Samson et al. | Jun 2002 | A1 |
20020123765 | Sepetka et al. | Sep 2002 | A1 |
20020138094 | Borillo et al. | Sep 2002 | A1 |
20020151928 | Leslie et al. | Oct 2002 | A1 |
20020169474 | Kusleika et al. | Nov 2002 | A1 |
20020188314 | Anderson et al. | Dec 2002 | A1 |
20020193825 | Mcguckin et al. | Dec 2002 | A1 |
20030004542 | Wensel et al. | Jan 2003 | A1 |
20030023265 | Forber | Jan 2003 | A1 |
20030040771 | Hyodoh et al. | Feb 2003 | A1 |
20030050663 | Khachin et al. | Mar 2003 | A1 |
20030060782 | Bose et al. | Mar 2003 | A1 |
20030093087 | Jones et al. | May 2003 | A1 |
20030144687 | Brady et al. | Jul 2003 | A1 |
20030153935 | Mialhe | Aug 2003 | A1 |
20030176884 | Berrada et al. | Sep 2003 | A1 |
20030195556 | Stack et al. | Oct 2003 | A1 |
20040068288 | Palmer et al. | Apr 2004 | A1 |
20040073243 | Sepetka et al. | Apr 2004 | A1 |
20040079429 | Miller et al. | Apr 2004 | A1 |
20040133232 | Rosenbluth et al. | Jul 2004 | A1 |
20040138692 | Phung et al. | Jul 2004 | A1 |
20040153025 | Seifert et al. | Aug 2004 | A1 |
20040153118 | Clubb et al. | Aug 2004 | A1 |
20040172056 | Guterman et al. | Sep 2004 | A1 |
20040199201 | Kellett et al. | Oct 2004 | A1 |
20040199243 | Yodfat | Oct 2004 | A1 |
20040210116 | Nakao | Oct 2004 | A1 |
20040267301 | Boylan et al. | Dec 2004 | A1 |
20050004594 | Nool et al. | Jan 2005 | A1 |
20050033348 | Sepetka et al. | Feb 2005 | A1 |
20050038447 | Huffmaster | Feb 2005 | A1 |
20050043680 | Segal et al. | Feb 2005 | A1 |
20050043756 | Lavelle et al. | Feb 2005 | A1 |
20050049619 | Sepetka et al. | Mar 2005 | A1 |
20050055033 | Leslie et al. | Mar 2005 | A1 |
20050055047 | Greenhalgh | Mar 2005 | A1 |
20050059995 | Sepetka et al. | Mar 2005 | A1 |
20050080356 | Dapolito et al. | Apr 2005 | A1 |
20050085826 | Nair et al. | Apr 2005 | A1 |
20050085847 | Galdonik et al. | Apr 2005 | A1 |
20050085849 | Sepetka et al. | Apr 2005 | A1 |
20050090857 | Kusleika et al. | Apr 2005 | A1 |
20050090858 | Pavlovic | Apr 2005 | A1 |
20050125024 | Sepetka et al. | Jun 2005 | A1 |
20050131450 | Nicholson et al. | Jun 2005 | A1 |
20050171566 | Kanamaru | Aug 2005 | A1 |
20050203571 | Mazzocchi et al. | Sep 2005 | A1 |
20050209609 | Wallace | Sep 2005 | A1 |
20050216030 | Sepetka et al. | Sep 2005 | A1 |
20050216050 | Sepetka et al. | Sep 2005 | A1 |
20050234501 | Barone | Oct 2005 | A1 |
20050234505 | Diaz et al. | Oct 2005 | A1 |
20050277978 | Greenhalgh | Dec 2005 | A1 |
20050283166 | Greenhalgh | Dec 2005 | A1 |
20050283186 | Berrada et al. | Dec 2005 | A1 |
20060004404 | Khachin et al. | Jan 2006 | A1 |
20060009784 | Behl et al. | Jan 2006 | A1 |
20060030925 | Pryor | Feb 2006 | A1 |
20060047286 | West | Mar 2006 | A1 |
20060058836 | Bose et al. | Mar 2006 | A1 |
20060058837 | Bose et al. | Mar 2006 | A1 |
20060058838 | Bose et al. | Mar 2006 | A1 |
20060095070 | Gilson et al. | May 2006 | A1 |
20060129166 | Lavelle | Jun 2006 | A1 |
20060129180 | Tsugita et al. | Jun 2006 | A1 |
20060155305 | Freudenthal et al. | Jul 2006 | A1 |
20060190070 | Dieck et al. | Aug 2006 | A1 |
20060195137 | Sepetka et al. | Aug 2006 | A1 |
20060229638 | Abrams et al. | Oct 2006 | A1 |
20060253145 | Lucas | Nov 2006 | A1 |
20060271153 | Garcia et al. | Nov 2006 | A1 |
20060276805 | Yu | Dec 2006 | A1 |
20060282111 | Morsi | Dec 2006 | A1 |
20060287668 | Fawzi et al. | Dec 2006 | A1 |
20070112374 | Paul et al. | May 2007 | A1 |
20070118165 | Demello et al. | May 2007 | A1 |
20070149996 | Coughlin | Jun 2007 | A1 |
20070185500 | Martin et al. | Aug 2007 | A1 |
20070185501 | Martin et al. | Aug 2007 | A1 |
20070197103 | Martin et al. | Aug 2007 | A1 |
20070198029 | Martin et al. | Aug 2007 | A1 |
20070198030 | Martin et al. | Aug 2007 | A1 |
20070198051 | Clubb et al. | Aug 2007 | A1 |
20070225749 | Martin et al. | Sep 2007 | A1 |
20070233236 | Pryor | Oct 2007 | A1 |
20070265656 | Amplatz et al. | Nov 2007 | A1 |
20080109031 | Sepetka et al. | May 2008 | A1 |
20080183198 | Sepetka et al. | Jul 2008 | A1 |
20080188885 | Sepetka et al. | Aug 2008 | A1 |
20080262528 | Martin | Oct 2008 | A1 |
20080262532 | Martin | Oct 2008 | A1 |
20090069828 | Martin et al. | Mar 2009 | A1 |
20090105722 | Fulkerson et al. | Apr 2009 | A1 |
20090105737 | Fulkerson et al. | Apr 2009 | A1 |
20090125053 | Ferrera et al. | May 2009 | A1 |
20090192518 | Leanna et al. | Jul 2009 | A1 |
20090287291 | Becking et al. | Nov 2009 | A1 |
20090299393 | Martin et al. | Dec 2009 | A1 |
20100076452 | Sepetka et al. | Mar 2010 | A1 |
20100100106 | Ferrera | Apr 2010 | A1 |
20100174309 | Fulkerson et al. | Jul 2010 | A1 |
20100185210 | Hauser et al. | Jul 2010 | A1 |
20100217187 | Ferrera et al. | Aug 2010 | A1 |
20100256600 | Ferrera | Oct 2010 | A1 |
20100268264 | Bonnette | Oct 2010 | A1 |
20100318097 | Cragg et al. | Dec 2010 | A1 |
20110015718 | Schreck | Jan 2011 | A1 |
20110160742 | Ferrera et al. | Jun 2011 | A1 |
20110160757 | Ferrera et al. | Jun 2011 | A1 |
20110160760 | Ferrera et al. | Jun 2011 | A1 |
20110160761 | Ferrera et al. | Jun 2011 | A1 |
20110160763 | Ferrera et al. | Jun 2011 | A1 |
20110166586 | Sepetka et al. | Jul 2011 | A1 |
20110288572 | Martin | Nov 2011 | A1 |
20110319917 | Ferrera et al. | Dec 2011 | A1 |
20120143230 | Sepetka et al. | Jun 2012 | A1 |
20120197285 | Martin et al. | Aug 2012 | A1 |
20130030461 | Marks et al. | Jan 2013 | A1 |
20130281788 | Garrison | Oct 2013 | A1 |
20130289589 | Krolik | Oct 2013 | A1 |
20140005717 | Martin et al. | Jan 2014 | A1 |
20140276074 | Warner | Sep 2014 | A1 |
20140276403 | Follmer | Sep 2014 | A1 |
20140277013 | Sepetka et al. | Sep 2014 | A1 |
20140309656 | Gal et al. | Oct 2014 | A1 |
20140343595 | Monstadt et al. | Nov 2014 | A1 |
20150359547 | Vale et al. | Dec 2015 | A1 |
20160015402 | Brady et al. | Jan 2016 | A1 |
20160015935 | Chan et al. | Jan 2016 | A1 |
20160106448 | Brady et al. | Apr 2016 | A1 |
20160106449 | Brady et al. | Apr 2016 | A1 |
20160113663 | Brady et al. | Apr 2016 | A1 |
20160113665 | Brady et al. | Apr 2016 | A1 |
20160151618 | Powers et al. | Jun 2016 | A1 |
20160157985 | Vo et al. | Jun 2016 | A1 |
20160199620 | Pokorney et al. | Jul 2016 | A1 |
20160296690 | Kume et al. | Oct 2016 | A1 |
20160302808 | Loganathan et al. | Oct 2016 | A1 |
20160354098 | Martin et al. | Dec 2016 | A1 |
20160375180 | Anzai | Dec 2016 | A1 |
20170079766 | Wang et al. | Mar 2017 | A1 |
20170079767 | Leon-yip | Mar 2017 | A1 |
20170086862 | Vale et al. | Mar 2017 | A1 |
20170100143 | Grandfield | Apr 2017 | A1 |
20170105743 | Vale et al. | Apr 2017 | A1 |
20170164963 | Goyal | Jun 2017 | A1 |
20170215902 | Leynov et al. | Aug 2017 | A1 |
20170224953 | Tran et al. | Aug 2017 | A1 |
20170259042 | Nguyen | Sep 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20170290599 | Youn et al. | Oct 2017 | A1 |
20180049762 | Seip et al. | Feb 2018 | A1 |
20180084982 | Yamashita et al. | Mar 2018 | A1 |
20180116717 | Taff et al. | May 2018 | A1 |
20180132876 | Zaidat | May 2018 | A1 |
20180140314 | Goyal et al. | May 2018 | A1 |
20180140315 | Bowman et al. | May 2018 | A1 |
20180140354 | Lam et al. | May 2018 | A1 |
20180185614 | Garrison et al. | Jul 2018 | A1 |
20180325531 | Skillrud | Nov 2018 | A1 |
20180325532 | Skillrud | Nov 2018 | A1 |
20180325534 | Skillrud | Nov 2018 | A1 |
20180325535 | Skillrud | Nov 2018 | A1 |
20180368863 | Skillrud | Dec 2018 | A1 |
Number | Date | Country |
---|---|---|
1640505 | Jul 2005 | CN |
102036611 | Apr 2011 | CN |
3501707 | Jul 1986 | DE |
0200668 | Nov 1986 | EP |
1312314 | May 2003 | EP |
2319575 | Nov 2013 | EP |
2002537943 | Nov 2002 | JP |
2007522881 | Aug 2007 | JP |
2007252951 | Oct 2007 | JP |
2008539958 | Nov 2008 | JP |
2011508635 | Mar 2011 | JP |
2014004219 | Jan 2014 | JP |
2018118132 | Aug 2018 | JP |
20180102877 | Sep 2018 | KR |
WO 9409845 | May 1994 | WO |
WO 9509586 | Apr 1995 | WO |
WO 9601591 | Jan 1996 | WO |
WO 9617634 | Jun 1996 | WO |
WO 9619941 | Jul 1996 | WO |
WO 9727808 | Aug 1997 | WO |
WO 9727893 | Aug 1997 | WO |
WO 9803120 | Jan 1998 | WO |
WO 0053120 | Sep 2000 | WO |
WO 0072909 | Dec 2000 | WO |
WO 0132254 | May 2001 | WO |
WO 0154622 | Aug 2001 | WO |
WO 0167967 | Sep 2001 | WO |
WO 0228291 | Apr 2002 | WO |
WO 03000334 | Jan 2003 | WO |
WO 03061730 | Jul 2003 | WO |
WO 03089039 | Oct 2003 | WO |
WO 2006031410 | Mar 2006 | WO |
WO 2006122076 | Nov 2006 | WO |
WO 2007092820 | Aug 2007 | WO |
WO 2008036156 | Mar 2008 | WO |
WO 2008131116 | Oct 2008 | WO |
WO 2009034456 | Mar 2009 | WO |
WO 2009086482 | Jul 2009 | WO |
WO 2011091383 | Jul 2011 | WO |
WO 2012009675 | Jan 2012 | WO |
WO 2012162437 | Nov 2012 | WO |
WO 2013106146 | Jul 2013 | WO |
WO 2015141317 | Sep 2015 | WO |
WO 2017192999 | Nov 2017 | WO |
WO 2018019829 | Feb 2018 | WO |
WO 2018033401 | Feb 2018 | WO |
WO 2018046408 | Mar 2018 | WO |
WO 2018137029 | Aug 2018 | WO |
WO 2018137030 | Aug 2018 | WO |
WO 2018145212 | Aug 2018 | WO |
WO 2018156813 | Aug 2018 | WO |
WO 2018172891 | Sep 2018 | WO |
WO 2018187776 | Oct 2018 | WO |
Entry |
---|
European Search Report dated Feb. 8, 2021; European Patent Application No. 18819768.5; 8 pages. |
Number | Date | Country | |
---|---|---|---|
20200015988 A1 | Jan 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15626265 | Jun 2017 | US |
Child | 16580415 | US |